LIVN
LivaNova·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Buy"
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LIVN
Livanova Plc
A medical technology company that develops and manufactures cardiovascular and neuromodulation devices globally
Healthcare Equipment and Supplies
06/23/2015
10/19/2015
NASDAQ Stock Exchange
2,900
12-31
Common stock
20 Eastbourne Terrace, London, United Kingdom W2 6LG
--
LivaNova PLC was founded on June 23, 2015. The company is a medical device company. LivaNova is a limited liability company incorporated under the laws of England and Wales. Headquartered in London, UK, it is a global medical device manufacturing company focused on the development and delivery of critical treatment options for patients, healthcare professionals and the global healthcare system.
Earnings Call
Q1/2025
Estimate EPS0.76
Actual EPS0.88
Estimate Revenue302.37M
Actual Revenue316.90M
LivaNova's Q1 2025: Unraveling Contradictions on Cardiopulmonary Growth, Tariff Strategies, and OSPREY Efficacy
May 19,2025 04:36
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.87
Actual EPS1.05
Estimate Revenue332.21M
Actual Revenue352.50M
LivaNova's Q2 2025: Unraveling Contradictions in Capacity, Growth Potential, and Market Dynamics
Aug 07,2025 12:12
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.92
Actual EPS1.11
Estimate Revenue342.72M
Actual Revenue357.80M
LivaNova's Q3 2025 Earnings Call: Contradictions Emerge on Chinese Market Growth, Neuro Business, and R&D Strategy Shifts
Nov 05,2025 03:21
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LIVN has released its 2025 Q3 earnings. EPS was reported at 1.11, versus the expected 0.92, beating expectations. The chart below visualizes how LIVN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LIVN has released its 2025 Q3 earnings report, with revenue of 357.75M, reflecting a YoY change of 12.46%, and net profit of 26.78M, showing a YoY change of -18.72%. The Sankey diagram below clearly presents LIVN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
